您当前的位置:
首页 >
文章列表页 >
Randomized Controlled Trial of Traditional Chinese Medicine Sequential Syndrome Differentiation Protocol for Reducing Relapse Rate of Frequently Relapsing/Steroid-dependent Nephrotic Syndrome in Children
更新时间:2025-08-21
    • Randomized Controlled Trial of Traditional Chinese Medicine Sequential Syndrome Differentiation Protocol for Reducing Relapse Rate of Frequently Relapsing/Steroid-dependent Nephrotic Syndrome in Children

    • According to the latest research report, the sequential differentiation scheme of traditional Chinese medicine can reduce the recurrence rate of frequent recurrence/hormone dependent nephrotic syndrome in children, improve the remission rate, alleviate symptoms, and be clinically safe.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 18, Pages: 126-134(2025)
    • DOI:10.13422/j.cnki.syfjx.20252198    

      CLC: R242;R692;R256.5
    • Received:12 April 2025

      Accepted:14 July 2025

      Published Online:25 July 2025

      Published:20 September 2025

    移动端阅览

  • WANG Zhuiyue,REN Xianqing,PAN Wenqing,et al.Randomized Controlled Trial of Traditional Chinese Medicine Sequential Syndrome Differentiation Protocol for Reducing Relapse Rate of Frequently Relapsing/Steroid-dependent Nephrotic Syndrome in Children[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(18):126-134. DOI: 10.13422/j.cnki.syfjx.20252198.

  •  
  •  

0

Views

3

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis: A Randomized Controlled Trial
Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis
Randomized Controlled Study of Baoshen Prescription in Treating Stage Ⅳ Diabetic Nephropathy in Patients with Syndromes of Qi-Yin Deficiency and Kidney Collateral Stasis and Obstruction
Clinical Evidence Profile of Eleven Expensive Chinese Patent Medicines: A Scoping Analysis

Related Author

WANG Zhuiyue
REN Xianqing
PAN Wenqing
XU Tingting
ZHANG Xia
SONG Wei
YANG Lele
ZHANG Zhongyi

Related Institution

The First Affiliated Hospital of Henan University of Chinese MedicineZhengzhou
Pediatric Medicine College,Henan University of Chinese Medicine
Hospital of Chengdu University of TCM
Chengdu University of Traditional Chinese Medicine(TCM)
Liaoning University of Traditional Chinese Medicine(TCM)
0